| Cat. No. |
Product Name |
CAS No. |
Information |
| PC-38391 |
Evixapodlin
|
2374856-75-2 |
Evixapodlin (GS-4224) is a highly potent, small molecule human PD-1/PD-L1 protein-protein interaction inhibitor with IC50 of 0.213 nM, exhibits potential anticancer and antiviral activities. |
| PC-72654 |
CA-170
|
1673534-76-3 |
CA-170 (CA170) is a first-in-class, orally available, tripeptide small-molecule dual antagonist of VISTA/PD-L1, important negative checkpoint regulators of immune activation. |
| PC-35244 |
PD1-PD L1 inhibitor Polaris
|
2201132-36-5 |
PD1-PD L1 inhibitor Polaris is a novel potent, small molecule inhibitor of PD-1/PD-L1 interaction (IC50=0.1-10 nM in ELISA assays) with anti-cancer activity. |
| PC-70037 |
BMS-1166 hydrochloride
|
2113650-05-6 |
BMS-1166 Hcl salt is a potent PD-1/PD-L1 interaction inhibitor with IC50 of 1.4 nM in a homogenous time-resolved fluorescence binding assay. |
| PC-70036 |
BMS-1166
|
1818314-88-3 |
BMS-1166 is a potent PD-1/PD-L1 interaction inhibitor with IC50 of 1.4 nM in a homogenous time-resolved fluorescence binding assay. |
| PC-70035 |
BMS-1001 hydrochloride
|
2113650-04-5 |
BMS-1001 is a potent PD-1/PD-L1 interaction inhibitor with IC50 of 2.25 nM in a homogenous time-resolved fluorescence binding assay. |
| PC-70034 |
BMS-1001
|
2113650-03-4 |
BMS-1001 is a potent PD-1/PD-L1 interaction inhibitor with IC50 of 2.25 nM in a homogenous time-resolved fluorescence binding assay.. |
